Table 1.
Subject demographics and baseline values.
Parameter | All | Normal BMD | Osteoporosis/Osteopenia | p-Value |
---|---|---|---|---|
Men/Women | 26/32 | 13/16 | 13/16 | |
Age (years) | 71.6 ± 9.5 | 70.2 ± 10.3 | 73.0 ± 11.5 | p = 0.48 |
Follow-up time (days) | 183 ± 22 | 180 ± 16 | 186 ± 19 | p = 0.73 |
Baseline BMD (mg/cm3) | 137.1 ± 43.8 | 162.1 ± 32.5 | 92.7 ± 19.2 | p < 0.001 |
Baseline vertebral PDFF (%) | 45.7 ± 8.7 | 41.6 ± 9.3 | 49.7 ± 14.7 | p = 0.01 |
Baseline vertebral T2* (ms) | 9.0 ± 2.4 | 8.1 ± 2.3 | 9.9 ± 3.0 | p = 0.008 |
Baseline PSM PDFF (%) | 6.5 ± 5.1 | 4.7 ± 4.4 | 8.2 ± 10.3 | p = 0.10 |
Baseline PSM CSA (mm2) | 1302.7 ± 380.5 | 1359.7 ± 440.0 | 1245.7 ± 316.9 | p = 0.008 |
Note—Values are given as mean ± standard deviation. p-values for the significance of differences between the osteoporotic/osteopenic patients and patients with normal BMD are listed in the very right column.